Coviello, A.; Iacovazzo, C.; D’Abrunzo, A.; Ianniello, M.; Frigo, M.G.; Marra, A.; Buonanno, P.; Barone, M.S.; Servillo, G.; Vargas, M.
Sufentanil vs. Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section: A Mono-Centric Retrospective Comparative Study. J. Clin. Med. 2022, 11, 6868.
https://doi.org/10.3390/jcm11226868
AMA Style
Coviello A, Iacovazzo C, D’Abrunzo A, Ianniello M, Frigo MG, Marra A, Buonanno P, Barone MS, Servillo G, Vargas M.
Sufentanil vs. Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section: A Mono-Centric Retrospective Comparative Study. Journal of Clinical Medicine. 2022; 11(22):6868.
https://doi.org/10.3390/jcm11226868
Chicago/Turabian Style
Coviello, Antonio, Carmine Iacovazzo, Anella D’Abrunzo, Marilena Ianniello, Maria Grazia Frigo, Annachiara Marra, Pasquale Buonanno, Maria Silvia Barone, Giuseppe Servillo, and Maria Vargas.
2022. "Sufentanil vs. Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section: A Mono-Centric Retrospective Comparative Study" Journal of Clinical Medicine 11, no. 22: 6868.
https://doi.org/10.3390/jcm11226868
APA Style
Coviello, A., Iacovazzo, C., D’Abrunzo, A., Ianniello, M., Frigo, M. G., Marra, A., Buonanno, P., Barone, M. S., Servillo, G., & Vargas, M.
(2022). Sufentanil vs. Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section: A Mono-Centric Retrospective Comparative Study. Journal of Clinical Medicine, 11(22), 6868.
https://doi.org/10.3390/jcm11226868
